In PCa, it has been reported that TOP2A cooperates with androgen receptor (AR) to induce transcription of target genes, suggesting that androgen ablation therapy might be less effective in the presence of high level of TOP2A protein (Schaefer-Klein et al, 2015). The gene discussed is TOP2A; the disease is posterior cortical atrophy.